Completed PHASE3 INTERVENTIONAL 2-arm NCT00572039

Improving Function in Age-Related Macular Degeneration (IF-AMD)

Sponsor: Dartmouth College

Conditions Age-Related Macular Degeneration

Interventions PST ST

Updated 6 times since 2017 Last updated: Apr 11, 2025 Started: Aug 31, 2005 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00572039, this PHASE3 trial focuses on Age-Related Macular Degeneration and remains completed. Sponsored by Dartmouth College, it has been updated 6 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

May 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — May 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Aug 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dartmouth College
Johns Hopkins University
Thomas Jefferson University

Data source: Thomas Jefferson University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States